Related Experiment Video
Updated: Jun 7, 2026

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects
Published on: February 18, 2014
Hit-to-Lead Optimization of Energy-Coupling Factor (ECF) Transporter Inhibitors as Novel Antibiotic
Ioulia Exapicheidou1,2, Aleksei Tsarenko3, Lena Zeller1,2
1Helmholtz Institute for Pharmaceutical Research (HIPS) - Helmholtz Centre for Infection Research (HZI), Campus Building E 8.1, Saarbrücken, Saarland D-66123, Germany.
Abstract:
Multiparameter optimization of a previously identified class of inhibitors of the energy-coupling factor (ECF) transporters enabled the confirmation of in vivo efficacy. ECFs are a class of transmembrane proteins that play a vital role in the active translocation of essential nutrients across cell membranes and are therefore important in the fight against antimicrobial resistance. Aiming to improve the drug-like properties of our inhibitory class, we performed a focused structure-activity relationship study around the Eastern part of our starting molecule 3 by exploiting click chemistry. Our multiparameter optimization resulted in compounds with enhanced metabolic stability and solubility, potent activity against both a panel of Gram-positive bacteria, and against the ECF transporters. We further demonstrate rapid bacterial killing using Enterococcus faecium as a model organism and confirmed in vivo efficacy of the best compounds in Galleria mellonella larvae and Danio rerio (zebrafish) infection models, highlighting the therapeutic potential of our approach.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
ABC Transporters: Exporter
Inhibitors of Bacterial Protein Synthesis
Antibiotic Selection
Production of Pharmaceuticals
Production of Antibiotics

